Impact of Innovations on the Genome-Based Drug Market 2034
According to industry estimates, the sector was valued at US$ 15.64 billion in 2025 and is projected to reach US$ 44.44 billion by 2034, registering a CAGR of 12.30% during the forecast period from 2026 to 2034.
